Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
7 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Trodelvy“
Suchtreffer
Begriffe & Kennungen
Trodelvy · 4.8 · The frequencies of adverse reactions are based on pooled data from four clinical studies involving 963 patient
Eintrag öffnenTrodelvy · 4.8 · The most common adverse reactions reported in patients treated with sacituzumab govitecan were: neutropenia (6
Eintrag öffnenTrodelvy · 4.8 · The most common grade 3 or higher adverse reactions were neutropenia (48.6%), diarrhoea (10.0%), leukopenia (9
Eintrag öffnenTrodelvy · 4.8 · The most frequently reported serious adverse reactions in patients treated with sacituzumab govitecan were feb
Eintrag öffnenTrodelvy · 4.8 · The safety of sacituzumab govitecan in combination with pembrolizumab has also been evaluated in a clinical st
Eintrag öffnenTrodelvy · 4.8 · Use in patients with reduced UGT1A1 activity The incidence of Grade 3-4 neutropenia was 59.6% in patients homo
Eintrag öffnenTrodelvy · 4.8 · When sacituzumab govitecan is administered in combination with pembrolizumab, refer to the SmPC for the respec
Eintrag öffnen